Deutsche Bank’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Deutsche Bank’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-40	Closed	-$1K	–	5521
2015 Q1	$1K	Sell	40 -135	-77%	-$6.27K	﹤0.01%	5050
2014 Q4	$6K	Hold	175	–	–	﹤0.01%	5851
2014 Q3	$7K	Hold	175	–	–	﹤0.01%	5483
2014 Q2	$10K	Hold	175	–	–	﹤0.01%	5510
2014 Q1	$1K	Buy	+175	New	+$11.6K	﹤0.01%	5507

Deutsche Bank's ARNA Position: Q1 2022 in Review

Deutsche Bank sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 239,093 shares — an estimated $22.2M sold.

Deutsche Bank first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $22.2M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Deutsche Bank reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Deutsche Bank sold 239,093 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $22.2M.
Deutsche Bank first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
Deutsche Bank's Arena Pharmaceuticals Inc position peaked at $22.2M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Deutsche Bank's 13F filing for Q1 2022, filed 13 May 2022.